| Literature DB >> 16597462 |
Matthew A Joseph1, Megan L Mitchell, Jeffrey D Evanseck, Jeffrey R Kovacs, Liang Jia, Hongmei Shen, Wilson S Meng.
Abstract
We investigated analogues of GP2 (IISAVVGIL), an HLA-A*0201-restricted T-cell epitope derived from residues 654-662 in the tumor-associated antigen (TAA) Her-2/neu. One limiting factor of GP2 is its poor affinity for HLA-A*0201. Conformational analysis revealed the P5-P7 region in GP2 appears to be linked to the stability of P9 side chain interaction with the MHC molecule. To identify variants of GP2 with enhanced presentation to HLA-A*0201, we tested V6S, V6T, V6Q, G7P, G7F, T6F7, and Q6F7 for their capacity to stabilize cell surface HLA-A*0201 molecules. Of the mono-substituted variants, V6Q and G7F exhibited superior stabilization as compared to GP2. Molecular dynamics simulations suggest the improved binding can be attributed to concerted motions in the central and C-terminal regions of the peptide. These data support the notion that amino acids in HLA-A*0201 epitopes may be inter-dependent. Priming HLA-A*0201 transgenic mice with G7F-loaded syngeneic dendritic cells stimulated mouse T cells to produce a higher level of INFgamma than mice immunized with GP2.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16597462 PMCID: PMC2430429 DOI: 10.1016/j.molimm.2006.02.027
Source DB: PubMed Journal: Mol Immunol ISSN: 0161-5890 Impact factor: 4.407